X-153058385-G-A
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_013364.6(PNMA3):c.1330G>A(p.Val444Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000334 in 1,210,826 control chromosomes in the GnomAD database, including 1 homozygotes. There are 154 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_013364.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PNMA3 | NM_013364.6 | c.1330G>A | p.Val444Ile | missense_variant | 2/2 | ENST00000593810.3 | |
PNMA3 | NM_001282535.2 | c.1305+25G>A | intron_variant | ||||
PNMA3 | XR_938508.4 | n.1605G>A | non_coding_transcript_exon_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PNMA3 | ENST00000593810.3 | c.1330G>A | p.Val444Ile | missense_variant | 2/2 | NM_013364.6 | P1 | ||
PNMA3 | ENST00000619635.1 | c.1305+25G>A | intron_variant | 1 | |||||
PNMA3 | ENST00000424805.1 | c.1330G>A | p.Val444Ile | missense_variant, NMD_transcript_variant | 2/3 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.000470 AC: 53AN: 112683Hom.: 0 Cov.: 25 AF XY: 0.000517 AC XY: 18AN XY: 34821
GnomAD3 exomes AF: 0.000480 AC: 88AN: 183412Hom.: 1 AF XY: 0.000604 AC XY: 41AN XY: 67858
GnomAD4 exome AF: 0.000320 AC: 351AN: 1098143Hom.: 1 Cov.: 32 AF XY: 0.000374 AC XY: 136AN XY: 363503
GnomAD4 genome ? AF: 0.000470 AC: 53AN: 112683Hom.: 0 Cov.: 25 AF XY: 0.000517 AC XY: 18AN XY: 34821
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at